| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Janux Therapeutics, Inc. | Director | Common Stock | 74,098 | $1,893,944 | $25.56 | 11 Jun 2025 | Direct |
| AMEDISYS INC | Director | Common Stock | 0 | $898,445 | $91.51 | 14 Aug 2025 | Direct |
| Orthofix Medical Inc. | Director | Common Stock | 21,934 | $270,007 | $12.31 | 18 Jun 2025 | Direct |
| OTONOMY, INC. | Director | Common Stock | 3,400 | $299 | $0.0880 | 28 Nov 2022 | Direct |
| OTONOMY, INC. | Director | Common Stock | 1,600 | $141 | $0.0880 | 28 Nov 2022 | By Spouse |
| Orthofix Medical Inc. | Director | Employee Stock Option (Right to Buy) | 35,270 | 11 Mar 2025 | Direct | ||
| OTONOMY, INC. | Director | Stock Option (right to buy) | 27,500 | 21 Jun 2022 | Direct | ||
| Silverback Therapeutics, Inc. | Director | Stock Option (right to buy) | 18,000 | 10 Jun 2022 | Direct | ||
| Janux Therapeutics, Inc. | Director | Stock Option (right to buy) | 11,667 | 11 Jun 2025 | Direct | ||
| NUVASIVE INC | Director | RSUs | 4,816 | 09 Jun 2023 | Direct | ||
| NUVASIVE INC | Director | Common Stock, par value $0.001 per share | 0 | $42.67 | 01 Sep 2023 | Direct | |
| NUVASIVE INC | Director | Restricted Stock Unit | 0 | 01 Sep 2023 | Direct |